The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 19, 2019

Filed:

Mar. 04, 2013
Applicant:

The Governing Council of the University of Toronto, Toronto, CA;

Inventors:

Xiao Yu Wu, Toronto, CA;

Alireza Shalviri, Toronto, CA;

Ping Cai, Toronto, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C08F 251/00 (2006.01); A61K 9/14 (2006.01); A61K 31/197 (2006.01); A61K 47/36 (2006.01); A61K 38/08 (2006.01); A61K 31/704 (2006.01); A61K 47/32 (2006.01); C08J 3/14 (2006.01); C08F 8/00 (2006.01); A61K 9/51 (2006.01); A61K 49/00 (2006.01); A61K 49/18 (2006.01); B82Y 40/00 (2011.01);
U.S. Cl.
CPC ...
C08F 251/00 (2013.01); A61K 9/14 (2013.01); A61K 9/5161 (2013.01); A61K 9/5192 (2013.01); A61K 31/197 (2013.01); A61K 31/704 (2013.01); A61K 38/08 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01); A61K 49/0093 (2013.01); A61K 49/1818 (2013.01); A61K 49/1881 (2013.01); C08F 8/00 (2013.01); C08J 3/14 (2013.01); B82Y 40/00 (2013.01);
Abstract

Synthesis and characterization of starch based pH-responsive nanoparticles for controlled drug delivery are described. Polymethacrylic acid grafted starch (PMAA-g-St) nanoparticles with various molar ratio of starch to MAA were synthesized by a new one-pot method that enabled simultaneous grafting of PMAA and nanoparticle formation in an aqueous medium. NMR data showed that polysorbate 80 was polymerized into the graft polymer. Nanoparticles were relatively spherical with narrow size distribution and porous surface morphology and exhibited pH-dependent swelling in physiological pH range. The particle size and magnitude of volume phase transition were dependent on PMAA content and formulation parameters such as surfactant levels, cross-linker amount, and total monomer concentration. The results showed that the new pH-responsive nanoparticles possessed useful properties for controlled drug delivery.


Find Patent Forward Citations

Loading…